Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
X protein|precore/core protein|
Integrated sequence
GACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCAC| |CATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGAC
End
59118902/58607535 (Hg38)
Nearest miRNA
hsa-let-7e/Upstream/57159;
Upstream sequence
ttcagcacagacctggggggttagggttaggggtgccgttggggttggggttggggttagggttaggggttagggttagggttagggtttagggttaggg
Downstream sequence
tttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttagggttNNNNNNNNNNNNNNNNNNN
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.